1. Market has posted a growth of 7.52% for the month of June 2017, Anti-infectives has posted a positive growth for the month ( 3.1% growth), while Dermatology, Gastro Intestinal and Vitamins and mineral categories are growing lower than 10% on monthly basis
2. Major Chronic therapy like Anti-diabetic is driving a high double digit growth (18.3%).
3. Cardio segment has posted double digit growth for the month , CNS is still growing by single digit
6. Dataset : PharmaTrac MAT JUN 2017 (Val in Crs)(Val in Crs)
RANK SPLIT: Top 10 Contribute 42.75% to the IPM. Smaller and tail-
ender companies growing slower than the market
Jun-16 Jun-17
MAT VAL MS GR CORPORATE MAT VAL MS GR
103258 100.00 11.3 IPM 113739 100.00 10.1
44146 42.75 11.1 TOP 10 48682 42.80 10.3
28385 27.49 11.4 11-25 31465 27.66 10.9
14294 13.84 16.0 26 - 50 15798 13.89 10.5
10164 9.84 7.0 51 - 100 11135 9.79 9.5
6269 6.07 9.3 100 + 6660 5.86 6.2
42.75
27.49
13.84
9.84 6.07
JUN-16
TOP 10 11 - 25 26 - 50 51 - 100 100 +
42.80
27.66
13.89
9.79 5.86
JUN-17
TOP 10 11 - 25 26 - 50 51 - 100 100 +
7. Dataset : PharmaTrac MAT JUN 2017 (Val in Crs)(Val in Crs)
INDIAN/MNC SPLIT: Indian Companies dominate & are growing above the
Market on MAT basis. However for the Month June-17 MNC collectively
growing better than Indian companies
GR VAL : 10.8 GR VAL : 7.7IPM GR VAL : 10.1
0200040006000800010000
SUN*,
9726
CIPLA,
5308
ZYDUS*,
4977
MANKIN
D, 4180
ALKEM*,
3924
79.08
20.92
INDIAN MNC
0 2000 4000 6000 8000
ABBOTT*,
7015
GSK, 3415
PFIZER*,
2846
SANOFI
INDIA,
2534
NOVARTIS,
1075
8. Dataset : PharmaTrac MAT JUN 2017 (Val in Crs)(Val in Crs)
* Abbott + Abbott HC + Novo; Alkem + Indchemie + Cachet; Pfizer + Wyeth; Zydus + Biochem; Micro + Bal
ZONAL SPLIT: South dominates rest of the zones growing slower
than the IPM
26.8%
25.8%
20.1%
23.5%
JUN-17
20.1%
23.5%
20.2% 26.5%
22.4% 25.8%
20.2% 26.7%
22.1% 25.6%
SOUTH ZONE
NORTH ZONE
WEST ZONE
EAST ZONE
ZONE
JUN-16
MAT VAL JUN 17
ZONE MAT VAL MS MS (G / L) GR INCRE VAL
IPM 113739 100.00% 0.00% 10.1 10480
SOUTH ZONE 30421 26.75% 0.21% 11.0 3024
NORTH ZONE 29088 25.57% -0.24% 9.1 2429
WEST ZONE 25181 22.14% -0.24% 9.0 2074
EAST ZONE 22959 20.19% -0.04% 9.9 2076
ALL INDIA ONLY 6089 5.35% 0.31% 16.8 877
9. Dataset : PharmaTrac MAT JUN 2017 (Val in Crs)(Val in Crs)
Top 3 Markets constitutes 38.2% of IPM…….Anti-Diabetics adds Maximum
incremental value on MAT basis, followed by Anti-infectives and CVS….
MAT VAL JUN 17 MS
SUPERGROUP SV BV GR INCRE VAL BV % TO SV SV BV
IPM 113739 4273 10.1 10480 3.8 100.00 100.00
ANTI-INFECTIVES 16217 1255 4.6 708 7.7 14.26 29.37
CARDIAC 14025 122 11.4 1433 0.9 12.33 2.84
GASTRO INTESTINAL 13198 464 9.9 1184 3.5 11.60 10.87
ANTI DIABETIC 10148 82 19.2 1637 0.8 8.92 1.91
VITAMINS / MINERALS / NUTRIENTS 9951 278 8.6 786 2.8 8.75 6.51
RESPIRATORY 8478 351 9.4 727 4.1 7.45 8.21
PAIN / ANALGESICS 7832 347 9.8 699 4.4 6.89 8.12
DERMA 6859 209 12.7 772 3.1 6.03 4.90
NEURO / CNS 6847 79 8.4 533 1.2 6.02 1.86
GYNAECOLOGICAL 5926 479 11.1 594 8.1 5.21 11.22
ANTI-NEOPLASTICS 2391 5 7.2 160 0.2 2.10 0.12
VACCINES 2131 117 20.3 360 5.5 1.87 2.74
OPHTHAL / OTOLOGICALS 2085 31 6.4 126 1.5 1.83 0.72
HORMONES 1918 16 9.0 159 0.8 1.69 0.38
BLOOD RELATED 1436 32 14.2 178 2.2 1.26 0.74
UROLOGY 1318 23 11.5 136 1.8 1.16 0.55
OTHERS 1241 48 16.1 172 3.9 1.09 1.12
SEX STIMULANTS / REJUVENATORS 653 230 16.9 94 35.3 0.57 5.39
ANTI MALARIALS 586 91 -1.0 -6.0 15.5 0.52 2.13
STOMATOLOGICALS 499 13 5.5 26 2.6 0.44 0.30